44.28
Exelixis Inc Aktie (EXEL) Neueste Nachrichten
EXELIXIS, INC. ($EXEL) CEO 2025 Pay Revealed - Quiver Quantitative
Executive pay and equity plan on ballot at Exelixis (NASDAQ: EXEL) 2026 meeting - Stock Titan
Exelixis: Stable Demand And High Margins With Undervalued Shares (NASDAQ:EXEL) - Seeking Alpha
Exelixis, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Here's why Exelixis (EXEL) is a strong growth stock - MSN
Working capital per share of Exelixis, Inc. – BX:EX9 - TradingView — Track All Markets
Exelixis Announces Webcast of March 4 Presentation at the 33rd Annual Cowen Health Care Conference - Yahoo
EXELAnnual Report (10-k) - ADVFN
Exelixis Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - ADVFN
Neuroendocrine Tumor Treatment Market size to cross $5.12 - openPR.com
How (EXEL) Movements Inform Risk Allocation Models - Stock Traders Daily
Exelixis Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Do Upgraded 2026 Earnings Forecasts Alter the Growth Narrative for Exelixis (EXEL)? - Sahm
Stock Report: Can Exelixis Inc sustain its profitability2026 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Nisa Investment Advisors LLC Has $6.16 Million Holdings in Exelixis, Inc. $EXEL - MarketBeat
Exelixis, Inc. (EXEL) Stock Forecasts - Yahoo Finance
Tema Etfs LLC Grows Position in Exelixis, Inc. $EXEL - MarketBeat
Allspring Global Investments Holdings LLC Has $60.31 Million Position in Exelixis, Inc. $EXEL - MarketBeat
Moving Averages: Is Exelixis Inc a play on infrastructure spendingGlobal Markets & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Exelixis, Inc. (EXEL) stock price, news, quote and history - Yahoo Finance UK
Here's Why Exelixis (EXEL) is a Strong Growth Stock - Eastern Progress
Exelixis: A Strong Contender in the Cancer Drug Market - The Globe and Mail
Kidney Cancer Drugs Market to Grow by $2 Billion During - GlobeNewswire
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Yahoo Finance
Exelixis Inc. (NASDAQ:EXEL) Presents a Compelling Value Investment Case - ChartMill
Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Exelixis, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Trading Systems Reacting to (EXEL) Volatility - Stock Traders Daily
Exelixis, Inc. $EXEL Stake Lowered by Assenagon Asset Management S.A. - MarketBeat
RBC Capital lowers Exelixis (EXEL) price target to $43 - MSN
MIC:EXEL-RM OCF Yield %: 8.20 — 52% Above Median - GuruFocus
Exelixis, Inc. $EXEL Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
RBC Capital Lowers Exelixis (EXEL) Price Target to $43 - Insider Monkey
15 Set-It-and-Forget-It Stocks to Buy in 2026 - Insider Monkey
Exelixis (MIC:EXEL-RM) NonCurrent Deferred Revenue : ₽0.00 Mil (As of Dec. 2025) - gurufocus.com
EXEL Technical Analysis | Trend, Signals & Chart Patterns | EXELIXIS INC (NASDAQ:EXEL) - ChartMill
EXEL Financials: Income Statement, Balance Sheet & Cash Flow | Exelixis Inc - Stock Titan
Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares - Stock Titan
Exelixis (NASDAQ:EXEL) Raised to Strong-Buy at Truist Financial - MarketBeat
Exelixis, Inc. $EXEL Shares Sold by Nordea Investment Management AB - MarketBeat
EXEL: Former Executive Joins Recursion Pharmaceuticals as New CM - GuruFocus
EXEL Stock Price, Quote & Chart | EXELIXIS INC (NASDAQ:EXEL) - ChartMill
Quarterly Trades: Will Exelixis Inc outperform its industry peersMarket Volume Report & Capital Protection Trade Alerts - baoquankhu1.vn
Private Client Services LLC Takes $1.99 Million Position in Exelixis, Inc. $EXEL - MarketBeat
Here's why Exelixis (EXEL) is a strong value stock - MSN
Strategic Investment Advisors MI Buys 27,659 Shares of Exelixis, Inc. $EXEL - MarketBeat
How Exelixis Inc. (EXEL) Affects Rotational Strategy Timing - Stock Traders Daily
Pharma Stocks Analysis 2026: Pfizer & Novo Nordisk Rebound, Exelixis GrowthNews and Statistics - IndexBox
Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance
The Best Healthcare Stocks to Buy With $50 Right Now - The Motley Fool
Portfolio Update: What is the earnings history of Exelixis Inc2026 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):